Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Weifan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2113-6591; OpenAlex author ID A5018426114. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2022: 6 papers · 2023: 1 paper

Papers 7

  1. Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215976↗
  2. NNK from tobacco smoking enhances pancreatic cancer cell stemness and chemoresistance by creating a β2AR-Akt feedback loop that activates autophagy. First author DOI 10.1002/1878-0261.13230↗
  3. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling. Co-author DOI 10.1038/s41419-022-05082-3↗
  4. Correction: Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling. Co-author DOI 10.1038/s41419-022-05236-3↗
  5. Autophagic Schwann cells promote perineural invasion mediated by the NGF/ATG7 paracrine pathway in pancreatic cancer. Co-author DOI 10.1186/s13046-021-02198-w↗
  6. Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma. Co-author DOI 10.3389/fgene.2022.940794↗
  7. RASAL2 mediated the enhancement of YAP1/TIAM1 signaling promotes malignant phenotypes of pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/ijbs.72204↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qingyong Ma · 6 shared papers, 2022–2023 · strength 0.87
  2. Weikun Qian · 6 shared papers, 2022–2023 · strength 0.87
  3. Zheng Wang · 6 shared papers, 2022–2023 · strength 0.87
  4. Zheng Wu · 5 shared papers, 2022–2023 · strength 0.73
  5. Simei Zhang · 5 shared papers, 2022–2023 · strength 0.71
  6. Wunai Zhang · 5 shared papers, 2022–2023 · strength 0.71
  7. Zeen Zhu · 5 shared papers, 2022 · strength 0.70
  8. Jiantao Mo · 3 shared papers, 2022 · strength 0.43
  9. Cancan Zhou · 2 shared papers, 2022–2023 · strength 0.30
  10. Bo Zhang · 2 shared papers, 2022 · strength 0.28
  11. Zhengdong Jiang · 1 shared paper, 2023 · strength 0.16
  12. Jingtao Gu · 1 shared paper, 2023 · strength 0.16
  13. Xin Chen · 1 shared paper, 2022 · strength 0.15
  14. Zheng Wu · 1 shared paper, 2022 · strength 0.14
  15. Shuai Wu · 1 shared paper, 2022 · strength 0.14
  16. Zheng Wang · 1 shared paper, 2022 · strength 0.14
  17. Li Li · 1 shared paper, 2022 · strength 0.14
  18. Yangyang Yue · 1 shared paper, 2022 · strength 0.14
  19. Keping Xie · 1 shared paper, 2022 · strength 0.14
  20. Wenbin Yang · 1 shared paper, 2022 · strength 0.13
  21. Junhui Li · 1 shared paper, 2022 · strength 0.13
  22. Shuo Chen · 1 shared paper, 2022 · strength 0.13
  23. Qinggong Yuan · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.